|
1
|
World Health Organization (WHO). WHO
Recommendations on Interventions to Improve Preterm Birth Outcomes.
World Health Organization, Geneva, 2015.
|
|
2
|
Santos JV, Correia C, Cabral F, Bernardes
J, Costa-Pereira A and Freitas A: Should European perinatal
indicators be revisited? Eur J Obstet Gynecol Reprod Biol.
170:85–89. 2013.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Blencowe H, Cousens S, Oestergaard MZ,
Chou D, Moller AB, Narwal R, Adler A, Vera Garcia C, Rohde S, Say L
and Lawn JE: National, regional, and worldwide estimates of preterm
birth rates in the year 2010 with time trends since 1990 for
selected countries: A systematic analysis and implications. Lancet.
379:2162–2172. 2012.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kinney MV, Lawn JE, Howson CP and Belizan
J: 15 Million preterm births annually: What has changed this year?
Reprod Health. 9(28)2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Salis ER, Reith DM, Wheeler BJ, Broadbent
RS and Medlicott NJ: Hyperglycaemic preterm neonates exhibit
insulin resistance and low insulin production. BMJ Paediatr Open.
1(e000160)2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kwinta P and Pietrzyk JJ: Preterm birth
and respiratory disease in later life. Expert Rev Respir Med.
4:593–604. 2010.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Demerath EW, Cameron N, Gillman MW, Towne
B and Siervogel RM: Telomeres and telomerase in the fetal origins
of cardiovascular disease: A review. Hum Biol. 76:127–146.
2004.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Greider CW and Blackburn EH: A telomeric
sequence in the RNA of Tetrahymena telomerase required for telomere
repeat synthesis. Nature. 337:331–337. 1989.PubMed/NCBI View
Article : Google Scholar
|
|
9
|
de Lange T: How telomeres solve the
end-protection problem. Science. 326:948–952. 2009.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Blasco MA: Telomeres and human disease.
Ageing, cancer and beyond. Nat Rev Genet. 6:611–622.
2005.PubMed/NCBI View
Article : Google Scholar
|
|
11
|
Brümmendorf TH and Balabanov S: Telomere
length dynamics in normal hematopoiesis and in disease states
characterized by increased stem cell turnover. Leukemia.
20:1706–1716. 2006.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kirwan M and Dokal I: Dyskeratosis
congenita, stem cells and telomeres. Biochim Biophys Acta.
1792:371–319. 2009.PubMed/NCBI View Article : Google Scholar
|
|
13
|
López-Otín C, Blasco MA, Partridge L,
Serrano M and Kroemer G: The hallmarks of aging. Cell.
153:1194–1217. 2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Weidner CI, Lin Q, Koch CM, Eisele L,
Beier F, Ziegler P, Bauerschlag DO, Jöckel KH, Erbel R, Mühleisen
TW, et al: Aging of blood can be tracked by DNA methylation changes
at just three CpG sites. Genome Biol. 15(R24)2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Horvath S: DNA methylation age of human
tissues and cell types. Genome Biol. 14(R115)2013.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Hannum G, Guinney J, Zhao L, Zhang L,
Hughes G, Sadda S, Klotzle B, Bibikova M, Fan JB, Gao Y, et al:
Genome-wide methylation profiles reveal quantitative views of human
aging rates. Mol Cell. 49:359–367. 2013.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Bocklandt S, Lin W, Sehl ME, Sánchez FJ,
Sinsheimer JS, Horvath S and Vilain E: Epigenetic predictor of age.
PLoS One. 6(e14821)2011.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Knight AK, Craig JM, Theda C,
Bækvad-Hansen M, Bybjerg-Grauholm J, Hansen CS, Hollegaard MV,
Hougaard DM, Mortensen PB, Weinsheimer SM, et al: An epigenetic
clock for gestational age at birth based on blood methylation data.
Genome Biol. 17(206)2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Beier F, Balabanov S, Buckley T, Dietz K,
Hartmann U, Rojewski M, Kanz L, Schrezenmeier H and Brümmendorf TH:
Accelerated telomere shortening in glycosylphosphatidylinositol
(GPI)-negative compared with GPI-positive granulocytes from
patients with paroxysmal nocturnal hemoglobinuria (PNH) detected by
proaerolysin flow-FISH. Blood. 106:531–533. 2005.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Beier F, Masouleh BK, Buesche G, Ventura
Ferreira MS, Schneider RK, Ziegler P, Wilop S, Vankann L,
Gattermann N, Platzbecker U, et al: Telomere dynamics in patients
with del (5q) MDS before and under treatment with lenalidomide.
Leuk Res, Sep 21, 2015 (Online ahead of print).
|
|
21
|
Beier F, Foronda M, Martinez P and Blasco
MA: Conditional TRF1 knockout in the hematopoietic compartment
leads to bone marrow failure and recapitulates clinical features of
dyskeratosis congenita. Blood. 120:2990–3000. 2012.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Werner B, Beier F, Hummel S, Balabanov S,
Lassay L, Orlikowsky T, Dingli D, Brümmendorf TH and Traulsen A:
Reconstructing the in vivo dynamics of hematopoietic stem cells
from telomere length distributions. Elife. 4(e08687)2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Bartolović K, Balabanov S, Berner B,
Bühring HJ, Komor M, Becker S, Hoelzer D, Kanz L, Hofmann WK and
Brümmendorf TH: Clonal heterogeneity in growth kinetics of
CD34+CD38-human cord blood cells in vitro is correlated with gene
expression pattern and telomere length. Stem Cells. 23:946–957.
2005.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Brummendorf TH, Ersoz I, Hartmann U,
Balabanov S, Wolke H, Paschka P, Lahaye T, Berner B, Bartolovic K,
Kreil S, et al: Normalization of previously shortened telomere
length under treatment with imatinib argues against a preexisting
telomere length deficit in normal hematopoietic stem cells from
patients with chronic myeloid leukemia. Ann N Y Acad Sci.
996:26–38. 2003.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Brümmendorf TH, Holyoake TL, Rufer N,
Barnett MJ, Schulzer M, Eaves CJ, Eaves AC and Lansdorp PM:
Prognostic implications of differences in telomere length between
normal and malignant cells from patients with chronic myeloid
leukemia measured by flow cytometry. Blood. 95:1883–1890.
2000.PubMed/NCBI
|
|
26
|
Brümmendorf TH, Maciejewski JP, Mak J,
Young NS and Lansdorp PM: Telomere length in leukocyte
subpopulations of patients with aplastic anemia. Blood. 97:895–900.
2001.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Rufer N, Brümmendorf TH, Kolvraa S,
Bischoff C, Christensen K, Wadsworth L, Schulzer M and Lansdorp PM:
Telomere fluorescence measurements in granulocytes and T lymphocyte
subsets point to a high turnover of hematopoietic stem cells and
memory T cells in early childhood. J Exp Med. 190:157–167.
1999.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Baerlocher GM, Vulto I, de Jong G and
Lansdorp PM: Flow cytometry and FISH to measure the average length
of telomeres (flow FISH). Nat Protoc. 1:2365–2376. 2006.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Friedrich U, Schwab M, Griese EU, Fritz P
and Klotz U: Telomeres in neonates: New insights in fetal
hematopoiesis. Pediatr Res. 49:252–256. 2001.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Aubert G, Baerlocher GM, Vulto I, Poon SS
and Lansdorp PM: Collapse of telomere homeostasis in hematopoietic
cells caused by heterozygous mutations in telomerase genes. PLoS
Genet. 8(e1002696)2012.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Okuda K, Bardeguez A, Gardner JP,
Rodriguez P, Ganesh V, Kimura M, Skurnick J, Awad G and Aviv A:
Telomere length in the newborn. Pediatr Res. 52:377–381.
2002.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Javed R, Chen W, Lin F and Liang H:
Infant's DNA methylation age at birth and epigenetic aging
accelerators. Biomed Res Int. 2016(4515928)2016.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Alisch RS, Barwick BG, Chopra P, Myrick
LK, Satten GA, Conneely KN and Warren ST: Age-associated DNA
methylation in pediatric populations. Genome Res. 22:623–632.
2012.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Turner KJ, Vasu V, Greenall J and Griffin
DK: Telomere length analysis and preterm infant health: The
importance of assay design in the search for novel biomarkers.
Biomark Med. 8:485–498. 2014.PubMed/NCBI View Article : Google Scholar
|
